MA29092B1 - Procédé de synthèse de salicylamides n-substitués - Google Patents

Procédé de synthèse de salicylamides n-substitués

Info

Publication number
MA29092B1
MA29092B1 MA29983A MA29983A MA29092B1 MA 29092 B1 MA29092 B1 MA 29092B1 MA 29983 A MA29983 A MA 29983A MA 29983 A MA29983 A MA 29983A MA 29092 B1 MA29092 B1 MA 29092B1
Authority
MA
Morocco
Prior art keywords
synthesis
substituted salicylamides
salicylamides
substituted
Prior art date
Application number
MA29983A
Other languages
English (en)
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29092(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29092B1 publication Critical patent/MA29092B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA29983A 2004-12-16 2007-06-11 Procédé de synthèse de salicylamides n-substitués MA29092B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
MA29092B1 true MA29092B1 (fr) 2007-12-03

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29983A MA29092B1 (fr) 2004-12-16 2007-06-11 Procédé de synthèse de salicylamides n-substitués

Country Status (24)

Country Link
US (1) US8461385B2 (fr)
EP (2) EP1838664B1 (fr)
JP (1) JP5224816B2 (fr)
KR (1) KR101287233B1 (fr)
CN (1) CN101080384B (fr)
AR (1) AR055007A1 (fr)
AU (1) AU2005315850B2 (fr)
BR (1) BRPI0519327A2 (fr)
CA (1) CA2587213C (fr)
ES (1) ES2547349T3 (fr)
GB (1) GB0427603D0 (fr)
GT (1) GT200500353A (fr)
IL (1) IL183366A0 (fr)
MA (1) MA29092B1 (fr)
MX (1) MX2007007211A (fr)
NO (1) NO338969B1 (fr)
PE (1) PE20060740A1 (fr)
PL (1) PL1838664T3 (fr)
PT (1) PT1838664E (fr)
RU (1) RU2404158C2 (fr)
TN (1) TNSN07229A1 (fr)
TW (1) TW200635880A (fr)
WO (1) WO2006063821A1 (fr)
ZA (1) ZA200703826B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080049128A (ko) 2005-09-19 2008-06-03 에미스페어 테크놀로지스, 인코포레이티드 Ｎ-(5-클로로살리실로일)-8-아미노카프릴산 이나트륨염의결정형
PL2215047T3 (pl) 2007-11-02 2014-05-30 Emisphere Tech Inc Sposób leczenia niedoborów witaminy b12
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
CA3141383A1 (fr) * 2019-05-20 2020-11-26 Lonza Guangzhou Pharmaceutical Ltd. Procede de preparation de carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175390B1 (fr) 1999-04-05 2005-02-02 Emisphere Technologies, Inc. Sels disodiques, monohydrates et solvates ethanol pour liberer des agents actifs
MXPA02003123A (es) * 1999-06-25 2003-08-20 Inst For Pharm Discovery Inc Acidos fenoxiaceticos substituidos.
WO2001070219A1 (fr) 2000-03-21 2001-09-27 Emisphere Technologies, Inc. Procede de preparation de salicylamides alkyles par un agent intermediaire dicarboxylate
WO2001092206A1 (fr) 2000-06-02 2001-12-06 Emisphere Technologies, Inc. Procede de preparation de salicylamides
JP2004521857A (ja) * 2000-06-29 2004-07-22 エミスフェアー・テクノロジーズ・インク 活性剤の送達のための化合物及び組成物
WO2002019969A2 (fr) * 2000-09-06 2002-03-14 Emisphere Technologies Inc. Acide (5-(2-hydroxy-4-chlorobenzoyl) aminovalerique et ses sels, compositions contenant l'acide et ses sels pour acheminer des agents actifs
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
EP2272501B1 (fr) * 2002-01-09 2013-03-20 Emisphere Technologies, Inc. Polymorphes de sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate
BR0307727A (pt) 2002-02-20 2005-01-25 Lilly Co Eli Fomulação
US20050054557A1 (en) 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
AU2005315850B2 (en) 2009-11-05
KR101287233B1 (ko) 2013-07-17
IL183366A0 (en) 2007-09-20
TW200635880A (en) 2006-10-16
CN101080384A (zh) 2007-11-28
CA2587213A1 (fr) 2006-06-22
EP1838664B1 (fr) 2015-07-15
EP1838664A1 (fr) 2007-10-03
CN101080384B (zh) 2011-06-15
ES2547349T3 (es) 2015-10-05
PL1838664T3 (pl) 2016-04-29
GB0427603D0 (en) 2005-01-19
TNSN07229A1 (en) 2008-11-21
WO2006063821A1 (fr) 2006-06-22
JP2008524142A (ja) 2008-07-10
BRPI0519327A2 (pt) 2009-01-13
RU2404158C2 (ru) 2010-11-20
MX2007007211A (es) 2007-08-15
NO338969B1 (no) 2016-11-07
PE20060740A1 (es) 2006-09-04
US8461385B2 (en) 2013-06-11
AR055007A1 (es) 2007-08-01
PT1838664E (pt) 2015-10-16
EP2955171A1 (fr) 2015-12-16
US20090253811A1 (en) 2009-10-08
GT200500353A (es) 2006-07-17
NO20073548L (no) 2007-09-17
RU2007126972A (ru) 2009-01-27
CA2587213C (fr) 2015-05-19
ZA200703826B (en) 2008-08-27
JP5224816B2 (ja) 2013-07-03
KR20070086276A (ko) 2007-08-27
AU2005315850A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
IL184184A0 (en) Process for the purification of duloxetine hydrochloride
DK2292607T3 (da) Fremgangsmåde til syntese af organiske forbindelser
IL185419A0 (en) Improved process for the synthesis of enantiomeric indanylamine derivatives
IL217212A0 (en) Process for the production of amides
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
IS2979B (is) Aðferð til að framleiða N-útskipt 2-sýanópýrrólídín
HK1102030A1 (en) Process for the synthesis of azetidinones
ZA200903889B (en) Process for the synthesis of moxifloxacin hydrochloride
GB0623764D0 (en) Process for the synthesis of hydromorphone
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
DE602005024305D1 (de) Verfahren zu synthese von glycolonitril
EG25547A (en) Process for the preparation of amines
FI20055666A0 (fi) Prosessi hiilivetykomponentin valmistamiseksi
MA29092B1 (fr) Procédé de synthèse de salicylamides n-substitués
NO20050885D0 (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
IL183597A0 (en) Manufacture process of n-substituted salicylamides
FR2894596B1 (fr) Procede d'autocalibration de biopuces
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
HU0402017D0 (en) Environment-friend process for the synthesis of quaternary ammonio-steroids
IL184354A0 (en) New one-step synthesis of useful disubstituted amines
DK1685104T3 (da) Fremgangsmåde til fremstilling af N-substituerede phthalomider
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
IL162071A0 (en) Process for synthesis of dinitrotetraoxadiazaisowurzitane (dtiw)
ZA200601986B (en) Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile